US Edition
News from Queens Chronicle
We’ve assigned a media bias rating of Lean Left to Queens Chronicle. You can read more about our methodology here.
If you want to know if Queens Chronicle is credible or reliable, look no further. We rank Queens Chronicle as High factuality. Find out more about our methodology here.
Information about Queens Chronicle
Where is Queens Chronicle located?Queens Chronicle's WebsiteQueens Chronicle's TwitterQueens Chronicle's WikipediaMedia Bias Ratings
Average Bias Rating:
Lean Left
Lean Left
byMedia Bias/Fact CheckDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Queens Chronicle News
Singapore, Singapore · SingaporeSINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP…See the Story
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
64% Center coverage: 33 sources
Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
55% Center coverage: 29 sources
